Dr. Gregory A. Masters
Dr. Gregory Masters is considered a lung cancer specialist in the field, serving patients at the Helen F. Graham Cancer Center after joining the Christiana Care Medical-Dental Staff in 2003. Dr. Masters also serves as an associate professor at the Thomas Jefferson University Medical School in Philadelpia.
To share his knowledge with others, Dr. Masters travels around the United States to talk about lung cancer with various audiences. A noted lecturer and published author on the topic of lung cancer, Dr. Masters is a reviewer for several prominent scientific publications relative to the field of oncology, including Lung Cancer, The Lancet, Cancer, Journal of Thoracic Oncology, Clinical Lung Cancer, Journal of Clinical Oncology, American Journal of Clinical Oncology, and the British Journal of Cancer.
Main Specialty: Oncology
Other Interests & Specialties: General oncology, hematologic oncology, thoracic cancer, lung cancer, esophageal cancer, gastrointestinal cancer, head and neck cancer and palliative care.
Certifications, Awards & Accolades: American Board of Internal Medicine Certifications in Internal Medicine and Medical Oncology, ACP Fellow, America's Top Doctors Award, America's Top Doctors for Cancer Award, Meredith Benjamin Award from Northwestern University Medical School, member of the American College of Physicians, the American Society of Clinical Oncology, the International Association for the Study of Lung Cancer, the Eastern Cooperative Oncology Group, Cancer and Leukemia Group B, the Radiation Therapy Oncology Group, the American College of Chest Physicians and the Medical Society of Delaware
Education & Experience:
- Residency for Internal Medicine University of Pennsylvania Health System
- Fellowship for Hematology/Oncology at University of Chicago
- Medical Degree from Northwestern University Feinberg School of Medicine
Case for Stopping Targeted Therapy When Lung Cancer Progresses on Treatment in Hospice-Eligible Patients. Journal of Oncology Practice. December 2017;13(12):780-783. doi: 10.1200/JOP.2017.027367
Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update. Journal of Clinical Oncology. October 2017;35(30):3484-3515. doi: 10.1200/JCO.2017.74.6065
Quality of Life Analysis of a Radiation Dose-Escalation Study of Patients With Non-Small-Cell Lung Cancer: A Secondary Analysis of the Radiation Therapy Oncology Group 0617 Randomized Clinical Trial. Jama Oncology. March 2016; 2(3):359-67. doi: 10.1001/jamaoncol.2015.3969